<VariationArchive RecordType="classified" VariationID="2422832" VariationName="NC_000004.11:g.(?_88896421)_(88979275_?)del" VariationType="Deletion" Accession="VCV002422832" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-02-18" DateCreated="2023-02-13" MostRecentSubmission="2023-02-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1939150" VariationID="2422832">
      <GeneList>
        <Gene Symbol="PKD2" FullName="polycystin 2, transient receptor potential cation channel" GeneID="5311" HGNC_ID="HGNC:9009" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>4q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="88007635" stop="88077777" display_start="88007635" display_stop="88077777" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="88928798" stop="88998930" display_start="88928798" display_stop="88998930" Strand="+" />
          </Location>
          <OMIM>173910</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SPP1" FullName="secreted phosphoprotein 1" GeneID="6696" HGNC_ID="HGNC:11255" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>4q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="87975714" stop="87983411" display_start="87975714" display_stop="87983411" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="88896801" stop="88904562" display_start="88896801" display_stop="88904562" Strand="+" />
          </Location>
          <OMIM>166490</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000004.11:g.(?_88896421)_(88979275_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" innerStart="88896421" innerStop="88979275" display_start="88896421" display_stop="88979275" variantLength="82855" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.(?_88896421)_(88979275_?)del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.(?_88896421)_(88979275_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000004.11:g.(?_88896421)_(88979275_?)del AND Autosomal dominant polycystic kidney disease" Accession="RCV003110966" Version="2">
        <ClassifiedConditionList TraitSetID="13731">
          <ClassifiedCondition DB="MedGen" ID="C0085413">Autosomal dominant polycystic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-02-13">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17582161</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22863349</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13731" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant polycystic kidney disease</ElementValue>
                <XRef ID="MONDO:0004691" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADPKD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10413" />
                <XRef ID="10413" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Spanish WG, 2014">
                <ID Source="PubMed">25165191</ID>
              </Citation>
              <XRef ID="730" DB="Orphanet" />
              <XRef ID="C0085413" DB="MedGen" />
              <XRef ID="MONDO:0004691" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7071616" SubmissionDate="2023-02-03" DateLastUpdated="2023-02-13" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000297.3_Deletion (Exons 1-9)|MedGen:CN119611" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003792091" DateUpdated="2023-02-13" DateCreated="2023-02-13" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17582161</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22863349</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1-9 of the PKD2 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKD2 are known to be pathogenic (PMID: 17582161, 22863349). This variant has not been reported in the literature in individuals affected with PKD2-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.(?_88896421)_(88979275_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN119611" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7071616" TraitType="Disease" MappingType="XRef" MappingValue="CN119611" MappingRef="MedGen">
        <MedGen CUI="C0085413" Name="Autosomal dominant polycystic kidney disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

